FOXF2 and metastatic malignant neoplasm in the lymph nodes: The patients along with ≥50 years or lymph node metastasis or myometrial invasion or III–IV TNM stage had much lower FOXF2 protein relative expression than the other patients (P<0.05 or P<0.01).